Richard Parsons

7.4k total citations · 3 hit papers
185 papers, 5.3k citations indexed

About

Richard Parsons is a scholar working on General Health Professions, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Richard Parsons has authored 185 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in General Health Professions, 29 papers in Surgery and 27 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Richard Parsons's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Antibiotic Use and Resistance (11 papers) and Family and Disability Support Research (10 papers). Richard Parsons is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Antibiotic Use and Resistance (11 papers) and Family and Disability Support Research (10 papers). Richard Parsons collaborates with scholars based in Australia, Sweden and United States. Richard Parsons's co-authors include Torbjörn Falkmer, Joseph Hung, David R. Hillman, Konrad Jamrozik, Marita Falkmer, Sharmila Vaz, Brendan Silbert, Paul S. Myles, Anne Passmore and John R. A. Rigg and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Richard Parsons

179 papers receiving 5.1k citations

Hit Papers

Association of sleep apnoea with myocardial infarction in... 1990 2026 2002 2014 1990 2002 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of sleep apnoea with myocardial infarction in men
    1990 702 citations David R. Hillman, Richard Parsons et al. The Lancet profile →
  2. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
    2002 621 citations Konrad Jamrozik, Richard Parsons et al. The Lancet profile →
  3. The Case for Using the Repeatability Coefficient When Calculating Test–Retest Reliability
    2013 372 citations Richard Parsons et al. PLoS ONE profile →

Peers

Richard Parsons
Suhail A.R. Doi Australia
Martin Hellmich Germany
Gayane Yenokyan United States
Tero Vahlberg Finland
Ben Vandermeer Canada
M. Koskenvuo Finland
Steven M. Schwartz United States
Elizabeth Barrett‐Connor United States
F. Javier Nieto United States
Per Winkel Denmark
Suhail A.R. Doi Australia
Richard Parsons
Citations per year, relative to Richard Parsons Richard Parsons (= 1×) peers Suhail A.R. Doi

Countries citing papers authored by Richard Parsons

Since Specialization
Citations

This map shows the geographic impact of Richard Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Parsons more than expected).

Fields of papers citing papers by Richard Parsons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Parsons. The network helps show where Richard Parsons may publish in the future.

Co-authorship network of co-authors of Richard Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Parsons. A scholar is included among the top collaborators of Richard Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Parsons. Richard Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azzopardi, Maree, Richard Parsons, Gemma Cadby, et al.. (2024). Identifying Risk of Postoperative Cardiorespiratory Complications in OSA. CHEST Journal. 166(5). 1197–1208.
2.
Frydrych, Agnieszka M., Richard Parsons, & Omar Kujan. (2023). Use of oral nutritional supplements in irradiated patients with head and neck cancer. Oral Diseases. 30(7). 4165–4173. 1 indexed citations
3.
Johnson, M. C., et al.. (2022). Cross-sectional Census Survey of Patients With Cancer who Received a Pharmacist Consultation in a Pharmacist Led Anti-cancer Clinic. Journal of Cancer Education. 37(5). 1553–1561. 7 indexed citations
4.
Czarniak, Petra, et al.. (2022). Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists. International Journal of Clinical Pharmacy. 44(2). 466–479. 12 indexed citations
5.
6.
Czarniak, Petra, et al.. (2020). Home medicines reviews and residential medication management reviews in Western Australia. International Journal of Clinical Pharmacy. 42(2). 567–578. 13 indexed citations
7.
Liew, Danny, et al.. (2020). Epidemiology of Heart Failure: Study of Heart Failure in the Australian Primary CarE Setting (SHAPE). ESC Heart Failure. 7(6). 3871–3880. 10 indexed citations
8.
Jones, Christopher W., Richard Parsons, & Piers Yates. (2020). Increased incidence of venous thromboembolism following hip or knee arthroplasty in winter. Journal of orthopaedic surgery. 28(2). 616581037–616581037.
9.
10.
Sunderland, Bruce, et al.. (2019). An evaluation of community pharmacists’ understanding of autism spectrum disorder: a cross-sectional study in Western Australia. International Journal of Pharmacy Practice. 28(1). 41–48. 4 indexed citations
11.
Czarniak, Petra, et al.. (2019). The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study. PLoS ONE. 14(1). e0211094–e0211094. 5 indexed citations
12.
Sim, Tin Fei, et al.. (2019). A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective. Research in Social and Administrative Pharmacy. 16(4). 511–521. 34 indexed citations
13.
Ladyshewsky, Richard K., et al.. (2017). Differences in the emotional intelligence between undergraduate therapy and business students and the population norms. eSpace (Curtin University). 18(3). 225–242. 6 indexed citations
14.
Hattingh, Laetitia, et al.. (2016). Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study. Substance Abuse Treatment Prevention and Policy. 11(1). 30–30. 7 indexed citations
15.
Hattingh, Laetitia, et al.. (2016). Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study. BMJ Open. 6(9). e011948–e011948. 61 indexed citations
16.
Ngune, Irene, et al.. (2015). Do Patients Treated for Colorectal Cancer Benefit from General Practitioner Support? A Video Vignette Study. Journal of Medical Internet Research. 17(11). e249–e249. 4 indexed citations
17.
Roberts, Brigit, et al.. (2007). Delirium in the intensive care unit: searching for causes and sources. Critical Care and Resuscitation. 9(1). 26–29. 7 indexed citations
18.
Norman, Paul E., Konrad Jamrozik, Michael Lawrence‐Brown, et al.. (2004). Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 329(7477). 1259–1259. 80 indexed citations
19.
Nidorf, Stefan M., Richard Parsons, Pauline Thompson, K. D. Jamrozik, & M. Hobbs. (1990). Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction.. BMJ. 300(6717). 71–74. 20 indexed citations
20.
Thompson, Peter L., Philip E. Aylward, J. Federman, et al.. (1988). Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction. The Lancet. 1(8579). 203–207. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suhail A.R. Doi Breakdown of academic impact, for papers by Martin Hellmich Breakdown of academic impact, for papers by Gayane Yenokyan Breakdown of academic impact, for papers by Tero Vahlberg Breakdown of academic impact, for papers by Ben Vandermeer Breakdown of academic impact, for papers by M. Koskenvuo Breakdown of academic impact, for papers by Steven M. Schwartz Breakdown of academic impact, for papers by Elizabeth Barrett‐Connor Breakdown of academic impact, for papers by F. Javier Nieto Breakdown of academic impact, for papers by Per Winkel
Rankless by CCL
2026